• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芬兰多发性硬化症患病率不断上升。

Increasing prevalence of multiple sclerosis in Finland.

作者信息

Sumelahti M L, Tienari P J, Wikström J, Palo J, Hakama M

机构信息

School of Public Health, University of Tampere and Department of Clinical Neurophysiology, Tampere University Hospital, Finland.

出版信息

Acta Neurol Scand. 2001 Mar;103(3):153-8. doi: 10.1034/j.1600-0404.2001.103003153.x.

DOI:10.1034/j.1600-0404.2001.103003153.x
PMID:11240562
Abstract

OBJECTIVES

To follow-up the prevalence trends of MS from 1983 to 1993 in western and southern Finland. MS epidemiology has been previously followed from 1964 to 1978 in these regions. The updated prevalences were correlated with incidence trends in the same period.

METHODS

Age-adjusted and age-specific MS prevalence rates were calculated for cases classified by Poser's criteria.

RESULTS

In the western health-care districts, Seinäjoki and Vaasa, prevalences in 1993 were 202/10(5) and 111/10(5). In the southern district Uusimaa the respective figure was 108/10(5). In Seinäjoki a significant 1.7-fold increase was found in 1993 as compared to 1983, mainly due to increased incidence. In Uusimaa a significant 1.2-fold increase in prevalence was found in the presence of stable incidence. In Vaasa prevalence was stable, although incidence was declining.

CONCLUSION

The prevalence of MS is increasing in Seinäjoki and Uusimaa but not in Vaasa. Both the prevalence and incidence in Seinäjoki are now among the highest reported.

摘要

目的

追踪1983年至1993年芬兰西部和南部多发性硬化症(MS)的患病率趋势。此前已对这些地区1964年至1978年的MS流行病学情况进行过追踪。将更新后的患病率与同期的发病率趋势进行关联分析。

方法

根据波泽尔(Poser)标准对病例进行分类,计算年龄调整后的和特定年龄组的MS患病率。

结果

在西部医疗保健区的塞纳约基(Seinäjoki)和瓦萨(Vaasa),1993年的患病率分别为202/10⁵和111/10⁵。在南部的新地区(Uusimaa),相应数字为108/10⁵。在塞纳约基,与1983年相比,1993年患病率显著增加了1.7倍,主要是由于发病率上升。在新地区,尽管发病率稳定,但患病率仍显著增加了1.2倍。在瓦萨,患病率稳定,尽管发病率在下降。

结论

MS的患病率在塞纳约基和新地区呈上升趋势,而在瓦萨则不然。塞纳约基的患病率和发病率目前均在报告的最高水平之列。

相似文献

1
Increasing prevalence of multiple sclerosis in Finland.芬兰多发性硬化症患病率不断上升。
Acta Neurol Scand. 2001 Mar;103(3):153-8. doi: 10.1034/j.1600-0404.2001.103003153.x.
2
Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses.芬兰的多发性硬化症:复发缓解型和原发进展型病程的发病率趋势及差异
J Neurol Neurosurg Psychiatry. 2003 Jan;74(1):25-8. doi: 10.1136/jnnp.74.1.25.
3
Regional and temporal variation in the incidence of multiple sclerosis in Finland 1979-1993.1979 - 1993年芬兰多发性硬化症发病率的地区和时间差异。
Neuroepidemiology. 2000 Mar-Apr;19(2):67-75. doi: 10.1159/000026241.
4
Multiple sclerosis in western Finland: evidence for a founder effect.芬兰西部的多发性硬化症:奠基者效应的证据。
Clin Neurol Neurosurg. 2004 Jun;106(3):175-9. doi: 10.1016/j.clineuro.2004.02.009.
5
The epidemiology of multiple sclerosis in Finland: increase of prevalence and stability of foci in high-risk areas.芬兰多发性硬化症的流行病学:高风险地区患病率上升及病灶稳定性
Acta Neurol Scand. 1983 May;67(5):255-62. doi: 10.1111/j.1600-0404.1983.tb04574.x.
6
The incidence of optic neuritis and its prognosis for multiple sclerosis.视神经炎的发病率及其在多发性硬化症中的预后。
Acta Neurol Scand. 1983 Dec;68(6):371-7. doi: 10.1111/j.1600-0404.1983.tb04846.x.
7
Occurrence of multiple sclerosis in central Finland: a regional and temporal comparison during 30 years.芬兰中部多发性硬化症的发病情况:30年间的区域和时间比较
Acta Neurol Scand. 2004 Nov;110(5):331-6. doi: 10.1111/j.1600-0404.2004.00326.x.
8
Changes in multiple sclerosis epidemiology in Finland over five decades.多发性硬化症在芬兰五十年间的流行病学变化。
Acta Neurol Scand. 2020 Sep;142(3):200-209. doi: 10.1111/ane.13295. Epub 2020 Jun 24.
9
Multiple sclerosis epidemiology in Finland: Regional differences and high incidence.芬兰多发性硬化症的流行病学:地区差异和高发率。
Acta Neurol Scand. 2019 Apr;139(4):353-359. doi: 10.1111/ane.13057. Epub 2019 Jan 3.
10
Prevalence and incidence of multiple sclerosis in the city of Monreale, Italy.意大利蒙雷阿莱市多发性硬化症的患病率和发病率。
J Neurol. 1998 Jan;245(1):40-3. doi: 10.1007/s004150050172.

引用本文的文献

1
Incidence and prevalence of multiple sclerosis during eras of evolving diagnostic criteria-a nationwide population-based registry study over five decades.不断演变的诊断标准时代多发性硬化症的发病率和患病率——一项基于全国人群登记的五十年研究
Mult Scler J Exp Transl Clin. 2025 Mar 16;11(1):20552173251326173. doi: 10.1177/20552173251326173. eCollection 2025 Jan-Mar.
2
The epidemiology, pathology and pathogenesis of MS: Therapeutic implications.多发性硬化症的流行病学、病理学及发病机制:治疗意义
Neurotherapeutics. 2025 Feb 27:e00539. doi: 10.1016/j.neurot.2025.e00539.
3
The Role of the Intestinal Microbiome in Multiple Sclerosis-Lessons to Be Learned from Hippocrates.
肠道微生物群在多发性硬化症中的作用——从希波克拉底身上汲取的教训
Biology (Basel). 2023 Nov 24;12(12):1463. doi: 10.3390/biology12121463.
4
Prevalence of multiple sclerosis in an urban population of Sivas province in Turkey.土耳其锡瓦斯省城市人口多发性硬化症的患病率。
Turk J Med Sci. 2019 Feb 11;49(1):288-294. doi: 10.3906/sag-1808-112.
5
Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.地磁扰动可能是多发性硬化症的环境风险因素:24 个国家 111 个地点的生态学研究。
BMC Neurol. 2012 Sep 24;12:100. doi: 10.1186/1471-2377-12-100.
6
Multiple sclerosis: is prevalence rising and if so why?多发性硬化症:患病率在上升吗?如果是,原因是什么?
Neuroepidemiology. 2011;37(3-4):236-7. doi: 10.1159/000334606. Epub 2011 Nov 30.
7
Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene.全基因组关联研究在多发性硬化症高危隔离人群中发现 STAT3 基因相关变异。
Am J Hum Genet. 2010 Feb 12;86(2):285-91. doi: 10.1016/j.ajhg.2010.01.017.
8
Use of a genetic isolate to identify rare disease variants: C7 on 5p associated with MS.利用遗传隔离群体鉴定罕见病变异:5号染色体短臂上的C7与多发性硬化症相关。
Hum Mol Genet. 2009 May 1;18(9):1670-83. doi: 10.1093/hmg/ddp073. Epub 2009 Feb 16.
9
The genome-wide patterns of variation expose significant substructure in a founder population.全基因组变异模式揭示了创始人群体中显著的亚结构。
Am J Hum Genet. 2008 Dec;83(6):787-94. doi: 10.1016/j.ajhg.2008.11.005.
10
No evidence for shared etiology in two demyelinative disorders, MS and PLOSL.在两种脱髓鞘疾病——多发性硬化症(MS)和视神经脊髓炎谱系疾病(PLOSL)中,没有证据表明存在共同病因。
J Neuroimmunol. 2009 Jan 3;206(1-2):86-90. doi: 10.1016/j.jneuroim.2008.10.005. Epub 2008 Nov 18.